Avalo Therapeutics Inc
NASDAQ:AVTX
Wall Street
Price Targets
AVTX Price Targets Summary
Avalo Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for
AVTX
is 35.7 USD
with a low forecast of 35.35 USD and a high forecast of 36.75 USD.
AVTX Last Price Targets
Avalo Therapeutics Inc
The latest public price target was made on Apr 16, 2024 by
Leland Gershell
from
Oppenheimer
,
who expects
AVTX
stock to
rise by 144%
over the next 12 months.
You can read more about this price target by viewing
the article on StreetInsider.
| Analyst | Price Target | Date | Article |
|---|---|---|---|
Leland Gershell
Oppenheimer
|
35
USD
Upside 144% |
2 weeks ago
Apr 16, 2024
|
Oppenheimer Upgrades Avalo Therapeutics (AVTX) to Outperform following AVTX-009 acquisition
StreetInsider
|
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is AVTX's stock price target?
Price Target
35.7
USD
According to Wall Street analysts, the average 1-year price target for
AVTX
is 35.7 USD
with a low forecast of 35.35 USD and a high forecast of 36.75 USD.
What is Avalo Therapeutics Inc's Revenue forecast?
Projected CAGR
-19%
The
compound annual growth rate
of Avalo Therapeutics Inc's revenue for the next 3 years is
-19%.
You don't have any saved screeners yet
